Deutsche Bank Maintains Buy on ModivCare, Lowers Price Target to $50
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst Pito Chickering maintains a 'Buy' rating on ModivCare (NASDAQ:MODV) but has lowered the price target from $75 to $50.
August 07, 2023 | 4:14 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Deutsche Bank has maintained a 'Buy' rating on ModivCare but lowered the price target from $75 to $50.
The news is directly related to ModivCare and is likely to influence investor sentiment. While the 'Buy' rating is maintained, the reduction in price target might create some uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100